Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

British Journal of Cancer

Volumn 94, Issue 2, 2006, Pages 287-292

  Ward, D G ^a   Cheng, Y ^a   N'Kontchou, G ^b   Thar, T T ^b   Barget, N ^b   Wei, W ^a   Billingham, L J ^a   Martin, A ^a   Beaugrand, M ^b   Johnson, P J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Hepatocellular carcinoma; Proteome; SELDI; Serum

Indexed keywords

PROTEOME;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER DIAGNOSIS; CLASSIFICATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEROLOGY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; LIVER CIRRHOSIS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NEURAL NETWORKS (COMPUTER); PROTEINS; PROTEOME; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 31444448789     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602923     Document Type: Article

References (25)

1. Adam B-L, Qu YQ, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright Jr GL (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62: 3609-3614
2. Baggerly KA, Morris JS, Coombes KR (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing data sets from different experiments. Bioinformatics 20: 777-785
3. Beaugrand M, N'kontchou G, Seror O, Ganne N, Trinchet J-C (2005) Local/regional and systemic treatments of hepatocellular carcinoma. Semin Liver Dis 205: 201-211
4. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B (Methodol) 57: 289-300
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35: 421-430
6. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen CS (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N Engl J Med 336: 1855-1859
7. Chen Y, Zheng S, Yu J-K, Hu X (2004) Artificial neural networks analysis of surface-enhanced laser desorbtion/ionisation mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 10: 8380-8385
8. Diamandis EP (2004) Mass spectrometry as a diagnostic and a cancer biomarker discovery tool. Mol Cell Proteom 3: 367-378
9. Di Bisceglie AM, Order SE, Klein JL, Waggoner JG, Sjogren MH, Kuo G, Houghton M, Choo Q-L, Hoofnagle JH (1991) The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 86: 335-338
10. El-Sarag HB, Hashem B (2004) Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35: S72-S78
11. Gupta S, Bent S, Kohlwes J (2003) Test characteristic of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with heaptitis C. A systematic review and critical analysis. Ann Internal Med 139: 46-50
12. Johnson PJ (2001) The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. In: Clinics in Liver Disease, Di Bisceglie A (ed) Vol. 5, pp 145-159. Philadelphia: WB Saunders
13. Khan J, Wei WS, Ringner M, Saal LH, Ladanyi M, Westerman F, Berthold F, Schwab M, Antonescu C, Peterson C, Meltzer PS (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7: 673-679
14. Li J, Rosenzweig JM, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48: 1296-1304
15. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A (1996) Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699
16. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, Janeau J-L, Bezeaud A, Delforge D, Cubizolles M, Laurendeau I, Bedossa P (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver disease. Hepatology 41: 40-47
17. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156
18. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Instit 93: 1054-1061
19. Poon TCW, Yip T-T, Chan ATC, Yip C, Yip V, Mok TSK, Lee CCY, Leung TWT, Ho SKW, Johnson PJ (2003) Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 49: 752-760
20. Ransohoff DF (2004) Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev: Cancer 4: 309-313
21. Schwegler EE, Cazares L, Steel LF, Adam B-L, Johnson DA, Semmes OJ, Block TM, Marrero JA, Drake RR (2005) SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 41: 634-642
22. Sherman M (2005) Screening for hepatocellular carcinoma. Best Practice Res Clin Gastroenterol 19: 101-118
23. Trevisani F, De NS, Rappaccini G, Farinati F, Benvegnu L, Zoli M, Grazi GL, Del PP, Di N, Bernardi M (2002) Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 97: 734-744
24. Wilson EB (1927) Probable inference, the law of succession, and statistical inference. J Am Statist Assoc 22: 209-212
25. Zhang Z, Bast Jr B, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng X-Y, Berchuk A, Haaftenday CV, Hacker NF, Bruijn HWA, Zee AGVD, Jacobs IJ, Fung ET, Chan DW (2004) Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64: 5882-5890